Featured Abstracts
Review key findings and research highlights presented at major industry conferences and events.
Featured Content
ESTRO 2026
Preoperative radiotherapy in a single fraction for early stage breast cancer: the CRYSTAL phase I/II study update (AIRC IG-23118)
ESTRO 2026
Initial clinical experience of RayStation-based online adaptive RT using Radixact for endometrial cancer.
ESTRO 2026
One-year cumulative toxicity in 25 prostate cancer patients treated with single fraction (24 Gy) urethra-sparing radiosurgery (PRO-FAST NCT05936736 )
Featured Case Studies

Robotic Stereotactic Body Radiation Therapy For High-risk Prostate Cancer: The Georgetown University Experience
This retrospective study examines cancer control and health-related quality of life (HRQOL) outcomes in high-risk prostate cancer patients receiving robotic stereotactic body radiation therapy (SBRT) with Synchrony® real-time adaptive motion management.

Use of Motion Management to Model Unmanaged Motion: Dosimetric Consequences of Unmanaged Prostate Motion Assessed Using Real-time Radiotherapy Adaptation Data
This case report explores the dosimetric impact of unmanaged intrafraction prostate motion during radiotherapy by retrospectively analyzing real-time motion data collected using the Radixact® System with Synchrony®. The study models what would have happened if a patient had been treated without motion management, using deformation vector fields to simulate dose

Stereotactic Body Radiotherapy of a Lung Tumor with Large Respiratory Motion Using Real-time Adaptive Motion Management: A Case Report
Traditional internal target volume (ITV) methods for the treatment of a lung tumor on conventional linac would require a large planning target volume (PTV), risking high radiation exposure to the chest wall and lungs.
Impact of alternating-day fractionation on treatment outcome and toxicity in CyberKnife prostate SBRT
Michaela Jindráková, Czech Republic | ESTRO | 2026
Stereotactic body radiation therapy for intermediate-risk prostate cancer: efficacy and toxicity
María Dolores Espinosa Cuesta | ESTRO | 2026
DVH-based analysis of genitourinary side effects in robotic SBRT prostate treatments
David Sevillano, Spain | ESTRO | 2026
Planning, patient QA and image-guidance aspects of single-fraction, one-Day robotic SBRT for localized prostate cancer.
SARA BROGGI, Italy | ESTRO | 2026
Cyberknife Radiosurgery of Prostate Cancer – Results for 200 Patients
Sebastian Exner, Germany | ESTRO | 2026
Volumetric analysis of Vestibular Schwannoma after Cyberknife Stereotactic Radiosurgery/SBRT: single center study
Maris Mezeckis, Latvia | ESTRO | 2026
Anlotinib Plus Radiotherapy for Newly Diagnosed Pediatric Malignant Brainstem Gliomas: Safety and Efficacy Evaluation
Ying Wang, China | ESTRO | 2026
Cyberknife Stereotactic Radiosurgery For Vestibular Schwannoma: 9-Year Single-Centre Experience
Sandra Lediņa, Latvia | ESTRO | 2026
Dosimetric and Treatment Efficiency Comparison of IRIS versus MLC Collimators in CyberKnife Radiosurgery for Brain AVMs
Bhooshan Zade, India | ESTRO | 2026
Acoustic Neurinomas Treated with CyberKnife® SRS: Early Experience on Tolerability and Feasibility
Federica Pavoncello, Italy | ESTRO | 2026
Local control after stereotactic radiosurgery and fractionated stereotactic radiotherapy for cerebellopontine angle tumours
Łukasz Raszewsk | ESTRO | 2026
Dosimetric performance of Fixed and MLC collimators in robotic stereotactic radiosurgery for brain metastases
Anna Pederzoli, Italy | ESTRO | 2026
Optimizing Treatment Planning for Acoustic Neuromas with CyberKnife SRS: Preliminary Outcome Analysis
Federica Murtas, Italy | ESTRO | 2026